✦ LIBER ✦

A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinbiastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16)

Book ID: 122094317
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 132 KB
Volume: 16
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)82853-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin/ifosfamide/vinblastine (VIP) v

Cisplatin/ifosfamide/vinblastine (VIP) vs, cisplatin/ifosfamide etoposide (VIR-16) in non-small cell lung cancer (NSCLC). A prospective randomized phase III study

✍ Kosmidis, P.; Mylonakis, N.; Fountzilas, G.; Pavlidis, N.; Samantas, E.; Karabel 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 140 KB

208 Neoadjuvant chemotherapy ifosfamide

208 Neoadjuvant chemotherapy ifosfamide etoposide and cisplatin (VIP) in 50 patients with non small cell lung cancer (NSCLC)

✍ Roux, D.; Taiar, M.; Bay, J.O.; Kwiatkowski, F.; Escande, G.; Bardet, E.; Verrel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Randomized phase II trial comparing two

Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer: Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Cisplatin, etoposide, and ifosfamide in

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

✍ Adriano Paccagnella; Adolfo Favaretto; Alba Brandes; Cristina Ghiotto; Driano Fo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 2 views

Cisplatin, etoposide, and ifosfamide in

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase II study of chemotherapy with VP16

Phase II study of chemotherapy with VP16, ifosfamide and cisplatin (VIP) in the treatment of unresectable advanced non small cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 142 KB